The FDA has issued warning letters to 17 website operators for selling unapproved and misbranded opioids online in violation of the Federal Food, Drug, and Cosmetic Act. Misbranded opioids include those offered for sale without a prescription and opioids that lack adequate directions for use.
SEPTEMBER 14, 2020